Patents by Inventor Michelle T. Lane

Michelle T. Lane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090191534
    Abstract: Instead of immersing human reproductive cells in a single culture medium throughout the various procedures used in IVF, a process is provided by which the reproductive cells may be moved through a sequence of distinct culture media as the various IVF procedures are carried out. In one implementation, the culture media specifically formulated to provide a physical environment similar to that found within the female reproductive tract and conducive to growth and development of human reproductive cells during the various stages of the IVF process. In this regard, specifically formulated culture media can be applied to support the reproductive cells in one or more of the following procedures: oocyte retrieval and handling; oocyte maturation; ordinary fertilization; oocyte, zygote and embryo examination and biopsy; embryonic development to the eight-cell stage; embryonic development to the blastocyst stage; embryo transfer, and cryopreservation.
    Type: Application
    Filed: April 6, 2009
    Publication date: July 30, 2009
    Inventors: David K. GARDNER, Michelle T. LANE, Peter SVALANDER
  • Patent number: 7087370
    Abstract: The present invention relates to systems for the vitrification of a biological specimen. The systems employ a transfer instrument such as a loop, containing a base medium that includes a cryoprotectant. The biological specimen which has undergone vitrification may be stored for a period of time, and then thawed at a later date. The thawed biological specimen remains viable. Preferred biological specimens according to the present invention are developmental cells.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 8, 2006
    Inventors: Katrina T. Forest, Michelle T. Lane
  • Publication number: 20040214320
    Abstract: The present invention provides a supplement and a culture media useful for culturing mammalian gametes and embryonic tissue. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins. Additionally, because the medium is completely defined, the medium is not subject to variations which can impair the development of mammalian cells and prevent meaningful comparisons of empirical studies.
    Type: Application
    Filed: January 26, 2004
    Publication date: October 28, 2004
    Applicant: Vitrolife, Inc,
    Inventors: David K. Gardner, Michelle T. Lane
  • Patent number: 6762053
    Abstract: The present invention provides a supplement and a culture media useful for culturing mammalian gametes and embryonic tissue. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins. Additionally, because the medium is completely defined, the medium is not subject to variations which can impair the development of mammalian cells and prevent meaningful comparisons of empirical studies.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: July 13, 2004
    Assignee: Vitrolife, Inc.
    Inventors: David K. Gardner, Michelle T. Lane
  • Publication number: 20030113706
    Abstract: The present invention relates to a method of vitrification of a biological specimen. According to the method of the present invention, a biological specimen is directly exposed to a freezing material. Upon exposure to the freezing material, the biological specimen undergoes vitrification. The biological specimen which has undergone vitrification may be stored for a period of time, and then thawed at a later date. The thawed biological specimen remains viable. Preferred biological specimens according to the present invention are developmental cells.
    Type: Application
    Filed: September 10, 2002
    Publication date: June 19, 2003
    Applicant: Vitrolife Group
    Inventors: Katrina T. Forest, Michelle T. Lane
  • Patent number: 6500608
    Abstract: The present invention relates to a method of vitrification of a biological cells. According to the method of the present invention, biological cells are directly exposed to a vitrifying material. Upon exposure to the vitrifying material, the biological cells undergo vitrification. The biological cells which have undergone vitrification may be stored for a period of time, and then devitrified at a later date. The devitrified biological cells remain viable. Preferred biological cells according to the present invention are developmental cells.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: December 31, 2002
    Inventors: Katrina T. Forest, Michelle T. Lane
  • Publication number: 20020115054
    Abstract: The present invention relates to a method of vitrification of a biological specimen. According to the method of the present invention, a biological specimen is directly exposed to a freezing material. Upon exposure to the freezing material, the biological specimen undergoes vitrification. The biological specimen which has undergone vitrification may be stored for a period of time, and then thawed at a later date. The thawed biological specimen remains viable. Preferred biological specimens according to the present invention are developmental cells.
    Type: Application
    Filed: October 13, 1999
    Publication date: August 22, 2002
    Inventors: KATRINA T. FOREST, MICHELLE T. LANE
  • Publication number: 20020042132
    Abstract: The present invention provides a supplement and a culture media useful for culturing mammalian gametes and embryonic tissue. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins. Additionally, because the medium is completely defined, the medium is not subject to variations which can impair the development of mammalian cells and prevent meaningful comparisons of empirical studies.
    Type: Application
    Filed: June 8, 2001
    Publication date: April 11, 2002
    Inventors: David K. Gardner, Michelle T. Lane